Sarah Ives

Vice President, Biopharma at Triplebar Bio

Speaker

Sarah Ives, VP of Biopharma, leads biologics discovery at Triplebar Bio to engineer novel T-cell engagers for solid tumors. She directs research to enable high throughput functional discovery, potency maturation, and safety profiling. She has a decade of experience in biologics discovery and characterization. She was one of the first employees at startup Distributed Bio and helped navigate the company to a successful exit for $100M. Over 5 years she drove the systems that made DBio profitable without outside investment. She directed contract research for >75 therapeutics discovery and engineering campaigns, of which several are now in the clinic. Simultaneously, she managed an international research program to develop a universal flu vaccine, funded by the Gates Foundation. She operated the vivarium in Central America and ran 6 animal studies in pigs and chickens, coordinated live challenge studies in the US in pigs and ferrets, and executed preclinical validation assays. Sarah and her flu research are featured prominently in a Netflix docuseries. She is an inventor on multiple patents and an author on multiple publications. She earned her B.S. in molecular biology at University of Wisconsin, Madison and her Masters at University of San Francisco. A cold water marathon swimmer and avid cyclist, outside of work she can be found in or near the Pacific.